These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16773211)

  • 21. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50.
    Turturro F; Von Burton G; Friday E
    Clin Cancer Res; 2007 Jun; 13(12):3724-30. PubMed ID: 17575238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of estrogen receptor signaling by gamma synuclein.
    Jiang Y; Liu YE; Lu A; Gupta A; Goldberg ID; Liu J; Shi YE
    Cancer Res; 2003 Jul; 63(14):3899-903. PubMed ID: 12873981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of gamma-synuclein contributes to cancer cell survival under endoplasmic reticulum stress.
    Hua H; Xu L; Wang J; Jing J; Luo T; Jiang Y
    J Pathol; 2009 Mar; 217(4):507-15. PubMed ID: 19009586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
    Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
    Guo J; Shou C; Meng L; Jiang B; Dong B; Yao L; Xie Y; Zhang J; Chen Y; Budman DR; Shi YE
    Int J Cancer; 2007 Sep; 121(6):1296-305. PubMed ID: 17534899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
    Sui M; Huang Y; Park BH; Davidson NE; Fan W
    Cancer Res; 2007 Jun; 67(11):5337-44. PubMed ID: 17545614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
    Flores ML; Castilla C; Ávila R; Ruiz-Borrego M; Sáez C; Japón MA
    Breast Cancer Res Treat; 2012 Jun; 133(3):917-28. PubMed ID: 22076480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
    Zhang B; Zhang Y; Dagher MC; Shacter E
    Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells.
    Wang J; He FT; Tzang CH; Fong WF; Xiao PG; Han R; Yang MS
    Yao Xue Xue Bao; 2005 Dec; 40(12):1099-104. PubMed ID: 16496673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
    Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806.
    Rincon M; Broadwater G; Harris L; Crocker A; Weaver D; Dressler L; Berry D; Sutton L; Michaelson R; Messino M; Kirshner J; Fleming G; Winer E; Hudis C; Appel S; Norton L; Muss H;
    Breast Cancer Res Treat; 2006 Dec; 100(3):301-8. PubMed ID: 16773437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
    Ravizza R; Gariboldi MB; Molteni R; Monti E
    Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GBP1 overexpression is associated with a paclitaxel resistance phenotype.
    Duan Z; Foster R; Brakora KA; Yusuf RZ; Seiden MV
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):25-33. PubMed ID: 16028104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SNCG shRNA suppressed breast cancer cell xenograft formation and growth in nude mice.
    Shen PH; Fan QX; Li YW; Zhang W; He XK; Wang Z; Zhang YH
    Chin Med J (Engl); 2011 May; 124(10):1524-8. PubMed ID: 21740810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium sensing receptor down-regulates malignant cell behavior and promotes chemosensitivity in human breast cancer cells.
    Liu G; Hu X; Chakrabarty S
    Cell Calcium; 2009 Mar; 45(3):216-25. PubMed ID: 19038444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.